NF-κB激酶亚基ε抑制剂通过小胶质细胞活化参与狼疮易感小鼠的神经精神表现
本研究对狼疮易感MRL/lpr小鼠的小胶质细胞及体外细胞因子刺激的小胶质细胞进行RNA测序,鉴定出编码IKBKε的Ikbke上调;脑室内给予IKBKε抑制剂可改善MRL/lpr小鼠认知功能并抑制小胶质细胞活化,机制上IKBKε抑制降低糖酵解从而减弱小胶质细胞活化与吞噬。
要点
- MRL/lpr小鼠小胶质细胞及体外细胞因子刺激的小胶质细胞中Ikbke(编码IKBKε)表达上调。
- 脑室内给予IKBKε抑制剂改善MRL/lpr小鼠认知功能并抑制小胶质细胞活化。
- IKBKε抑制降低糖酵解,从而减弱小胶质细胞活化与吞噬。
核心结论
- 这些发现提示IKBKε通过小胶质细胞活化在NPSLE发病中起重要作用,并可能成为NPSLE的治疗靶点。
研究设计与样本
- 对狼疮易感MRL/lpr小鼠的小胶质细胞及体外经细胞因子培养的小胶质细胞进行RNA测序。
- 鉴定候选基因后,使用特异性抑制剂和小干扰RNA研究其在小胶质细胞活化与吞噬中的作用。
- 评估脑室内给予该抑制剂对MRL/lpr小鼠行为异常的影响。
主要发现
- 转录组分析显示,MRL/lpr小鼠小胶质细胞及体外细胞因子刺激的小胶质细胞中Ikbke(编码IKBKε)均上调。
- 脑室内给予IKBKε抑制剂改善MRL/lpr小鼠的认知功能并抑制小胶质细胞活化。
- 机制上,IKBKε抑制降低糖酵解,从而减弱小胶质细胞活化与吞噬。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by multiorgan dysfunction. Neuropsychiatric SLE (NPSLE) occurs in 30-40% of lupus patients and is the most severe presentation of SLE, frequently resulting in limitation of daily life. Recent studies have shown that microglia, tissue-resident macrophages in the central nervous system, are involved in the pathogenesis of NPSLE. This study was undertaken to explore new therapeutic targets for NPSLE focusing on microglia. METHODS: RNA sequencing of microglia in MRL/lpr, lupus-prone mice, as well as that of microglia cultured in vitro with cytokines were performed. A candidate gene, which could be a therapeutic target for NPSLE, was identified, and its role in microglial activation and phagocytosis was investigated using specific inhibitors and small interfering RNA. The effect of intracerebroventricular administration of the inhibitor on the behavioral abnormalities of MRL/lpr was also evaluated. RESULTS: Transcriptome analysis revealed the up-regulation of Ikbke, which encodes the inhibitor of NF-κB kinase subunit ɛ (IKBKε) in both microglia from MRL/lpr mice and cytokine-stimulated microglia in vitro. Intracerebroventricular administration of an IKBKε inhibitor ameliorated cognitive function and suppressed microglial activation in MRL/lpr mice. Mechanistically, IKBKε inhibition reduced glycolysis, which dampened microglial activation and phagocytosis. CONCLUSION: These findings suggest that IKBKε plays a vital role in the pathogenesis of NPSLE via microglial activation, and it could serve as a therapeutic target for NPSLE.
引用
- Karino K, Kono M, Takeyama S, et al. Inhibitor of NF-κB Kinase Subunit ε Contributes to Neuropsychiatric Manifestations in Lupus-Prone Mice Through Microglial Activation. Arthritis Rheumatol. 2023. PMID: 36098515. doi:10.1002/art.42352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。